☆ 4.6 Article

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

GYNECOLOGIC ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Lisa J. Vermij et al.

Summary: This study aimed to investigate whether adding hormone receptor expression, L1CAM expression or CTNNB1 status can improve the accuracy of risk assessment in endometrial cancer (EC). The study found that the expression of ER, PR, L1CAM, and CTNNB1 did not have independent prognostic value in EC, while age, stage, and adjuvant chemotherapy had an independent impact on the risk of recurrence. However, in high-risk EC of non-serous/mixed papillary (NSMP) subgroup, ER positivity was independently associated with a reduced risk of recurrence.

BRITISH JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification

Amy Jamieson et al.

Summary: This study measured the variation in practice across all aspects of endometrial cancer (EC) management and assessed the potential impact of molecular classification. The results showed significant differences in surgical practice, preoperative workup, and adjuvant therapy. Molecular subtyping was associated with patient survival. The study concluded that molecular classification has the potential to reduce disparities in EC care and guide treatment decisions.

GYNECOLOGIC ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer

Bob T. Li et al.

Summary: Trastuzumab deruxtecan demonstrated durable anticancer activity in previously treated HER2-mutant NSCLC patients, with two cases of fatal drug-related interstitial lung disease reported. The observed toxic effects were generally consistent with previous studies.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Pathology

Genomic landscape of endometrial carcinomas of no specific molecular profile

Amir Momeni-Boroujeni et al.

Summary: Based on mutation and copy number data, we identified three genomic clusters, with C3 cluster showing the worst prognosis for non-endometrioid NSMP-ECs.

MODERN PATHOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

J. Cortes et al.

Summary: Among patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and a taxane, trastuzumab deruxtecan was associated with a lower risk of disease progression or death compared to trastuzumab emtansine. However, treatment with trastuzumab deruxtecan was associated with interstitial lung disease and pneumonitis.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Oncology

Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Beryl L. Manning-Geist et al.

Summary: This study characterized the clinical and genetic features of MSI-H endometrial cancers with MMR gene mutations or MLH1 promoter hypermethylation. The results showed that MLH1ph endometrial cancers have distinct clinicopathologic features compared to germline and somatic MMR-D ECs, which may have implications for treatment.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas

Amir Momeni-Boroujeni et al.

Summary: This study investigated the clinicopathologic and molecular characteristics of non-hypermutant TP53-altered endometrial carcinomas of four histologic types. Despite differences in genomic alterations, TP53-mutated endometrial carcinomas showed similar overall survival across histologic types. Histologic classification remains relevant, particularly for serous carcinomas.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Genetic and molecular subtype heterogeneity in newly diagnosed early-and advanced-stage endometrial cancer

Arnaud Da Cruz Paula et al.

Summary: This study aimed to characterize and compare the molecular subtypes and profiles of 175 prospectively-accrued newly diagnosed early-and advanced-stage endometrial cancers. The results showed molecular subtypes present across histologic types, potentially helping stratify EC patients for prognostic and therapeutic purposes. Advanced-stage endometrial cancers had higher genomic complexity and certain genetic mutations were found across different histologic types.

GYNECOLOGIC ONCOLOGY (2021)

Add to Collection

Review Cell Biology

Incorporation of molecular characteristics into endometrial cancer management

Lisa Vermij et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Oncology

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

Naveena Singh et al.

JOURNAL OF PATHOLOGY (2020)

Add to Collection

Article Oncology

Interpretation of somatic POLE mutations in endometrial carcinoma

Alicia Leon-Castillo et al.

JOURNAL OF PATHOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Kohei Shitara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes

Kenneth L. Kehl et al.

JCO CLINICAL CANCER INFORMATICS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy

Mitsuhiro Nakamura et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Pathology

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

Tjalling Bosse et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Add to Collection

Article Oncology

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

S. Kommoss et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Article Oncology

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer

Casey M. Cosgrove et al.

GYNECOLOGIC ONCOLOGY (2018)

Add to Collection

Article Oncology

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

Amanda N. Fader et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Review Oncology

Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer

Rajmohan Murali et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

Add to Collection

Editorial Material Genetics & Heredity

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer

Malachi Griffith et al.

NATURE GENETICS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir et al.

NATURE MEDICINE (2017)

Add to Collection

Article Oncology

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

Jeroen Depreeuw et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts

Ellen Stelloo et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection

Article Oncology

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment

Aline Talhouk et al.

GYNECOLOGIC ONCOLOGY (2016)

Add to Collection

Article Oncology

A clinically applicable molecular-based classification for endometrial cancers

A. Talhouk et al.

BRITISH JOURNAL OF CANCER (2015)

Add to Collection

Article Pathology

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology

Donavan T. Cheng et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2015)

Add to Collection

Review Oncology

Classification of endometrial carcinoma: more than two types

Rajmohan Murali et al.

LANCET ONCOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Integrated genomic characterization of endometrial carcinoma

Gad Getz et al.

NATURE (2013)

Add to Collection

Article Oncology

Molecular, pathologic, and clinical features of early-onset endometrial cancer: Identifying presumptive lynch syndrome patients

Michael D. Walsh et al.

CLINICAL CANCER RESEARCH (2008)

Add to Collection

Article Pathology

Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma

Ippolito Modica et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.